Charles River Laboratories International, Inc. has plans to expand its global footprint in Asia as part of its strategy to support customers’ R&D efforts in this growing market. The first phase of expansion includes the signing of a joint venture agreement with Shanghai BioExplorer Co., Ltd., a Shanghai, China-based provider of preclinical services, to form Charles River Laboratories Preclinical Services – China. The joint venture will be majority owned and controlled by Charles River....